If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQXT.L Regulatory News (QXT)

  • There is currently no data for QXT

Director Shareholding

13 Oct 2020 07:00

RNS Number : 8508B
Quixant PLC
13 October 2020
 

 

13 October 2020

Quixant plc

("Quixant" or the "Company" or the "Group")

 

Director Shareholding

 

Quixant (AIM: QXT), a leading provider of specialised computing platforms and monitors for gaming and slot machine applications, announces that it was informed on 12 October 2020 that Jon Jayal, Chief Executive Officer purchased 4,191 ordinary shares of 0.1p each ("Ordinary Shares") at a price of 119.00 pence per Ordinary Share and 4,156 Ordinary Shares at a price of 120.00 pence per Ordinary Share (the "Purchases").

Following the Purchases, Jon Jayal is beneficially interested in 383,547 Ordinary Shares, representing approximately 0.58 per cent. of the Company's issued share capital.

The below notification, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail on the transactions.

 

Quixant plc

Tel: +44 (0)1223 892 696

Jon Jayal, Chief Executive Officer

Andrew Jarvis, Interim Chief Financial Officer

Nominated Adviser and Broker:

finnCap Ltd

Tel: +44(0)20 7220 0500

Matt Goode / Simon Hicks (Corporate Finance)

Alice Lane (Corporate Broking)

Financial PR:

Tel: +44 (0) 20 3405 0205

Alma PR

John Coles / Susie Hudson / David Ison / Kieran Breheny

 

About Quixant

 

Quixant, founded in 2005, was established as a designer and manufacturer of highly optimised computing and display solutions for the global gaming industry. Through the acquisition of Densitron Technologies plc in 2015, the Company diversified into other markets and has a focused technology offering for the broadcast sector, leveraging the business' extensive sector knowledge across many industries.

 

The Company is headquartered in Cambridge in the UK, with a global customer base and offices in North America, Europe and Asia. The Taiwanese operation is responsible for design, procurement and manufacturing of the Company's products. Quixant owns all its IP, some of which is protected by patents and design rights.

 

In-depth information on the Company's products, markets, activities and history can be found on the corporate website at www.quixant.com.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Jon Jayal

2.

Reason for the notification

a)

Position/status:

CEO

b)

Initial notification/Amendment:

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Quixant plc

 

b)

LEI:

2138003VERSWQP561X71

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 0.1p

 

GB00B99PCP71

b)

Nature of the transaction:

Purchase of ordinary shares of 0.1p

 

c)

Price(s) and volume(s):

Price(s)

Volume(s)

119.0p

4,191

120.0p

4,156

d)

Aggregated information:

· Aggregated volume:

· Price:

Purchase of 8,347 ordinary shares at an average price of 119.5p per ordinary share

e)

Date of the transaction:

12 October 2020

 

f)

Place of the transaction:

Off market transaction

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKKBBDFBDDQKD
Date   Source Headline
15th Mar 20177:00 amRNSSenior Management Update
2nd Mar 20177:00 amRNSNotice of Results
27th Jan 20177:00 amRNSTrading Update and Notice of Results
22nd Dec 201611:16 amRNSHolding(s) in Company
20th Dec 20165:06 pmRNSResult of Placing
20th Dec 20163:04 pmRNSProposed Secondary Placing
24th Nov 20162:05 pmRNSSecond Price Monitoring Extn
24th Nov 20162:00 pmRNSPrice Monitoring Extension
24th Nov 201611:05 amRNSSecond Price Monitoring Extn
24th Nov 201611:00 amRNSPrice Monitoring Extension
24th Nov 20167:00 amRNSTrading Update
21st Nov 20163:26 pmRNSAppointment of Company Secretary
27th Oct 20166:27 pmRNSHolding(s) in Company
19th Oct 20164:54 pmRNSIssue of Equity
6th Oct 20161:38 pmRNSIssue of Equity
21st Sep 20165:03 pmRNSHolding(s) in Company
14th Sep 20167:00 amRNSHalf-year Report
11th Aug 20167:00 amRNSNotice of Interim Results
27th Jul 20167:00 amRNSTrading Update and Notice of Results
20th Jun 20167:00 amRNSBoard Appointment
15th Jun 20164:57 pmRNSDirector Dealing
9th Jun 20164:32 pmRNSIssue of Equity
7th Jun 20167:00 amRNSHolding(s) in Company
23rd May 20168:17 amRNSSigning of Multi-Year Contract
26th Apr 201611:46 amRNSResult of AGM
6th Apr 20166:18 pmRNSDirector Dealing
6th Apr 20167:00 amRNSHolding(s) in Company
4th Apr 201610:53 amRNSCompleted Secondary Placing
23rd Mar 20167:00 amRNSFinal Results
19th Feb 20167:00 amRNSNotice of Results
15th Feb 201611:29 amRNSHolding(s) in Company
21st Jan 20167:00 amRNSTrading Update
13th Nov 20159:32 amRNSHolding(s) in Company
11th Nov 20157:00 amRNSCompletion of Acquisition
10th Nov 20153:40 pmRNSScheme of Arrangement Becomes Effective
6th Nov 201511:33 amRNSScheme of Arrangement Sanctioned By Court
3rd Nov 20155:13 pmRNSResults of Court Meeting and General Meeting
9th Oct 20157:00 amRNSPosting of Scheme Document
2nd Oct 201510:33 amRNSHolding in Company
1st Oct 20153:36 pmRNSForm 8 (OPD) Densitron Technologies plc
30th Sep 20153:33 pmRNSForm 8 (OPD) Quixant plc
25th Sep 20157:00 amRNSRule 2.7 Announcement
16th Sep 20157:00 amRNSHalf Yearly Report
3rd Aug 20159:48 amRNSHolding(s) in Company
22nd Jul 20157:00 amRNSTrading Update and Notice of Results
21st Apr 20157:00 amRNSQueen's Award for Enterprise
16th Apr 201511:01 amRNSResult of AGM
24th Mar 20151:41 pmRNSPosting of Annual Report and Accounts
24th Mar 20157:00 amRNSFinal Results
4th Mar 20157:00 amRNSNotice of Final Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.